These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1102 related items for PubMed ID: 21341156

  • 61. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P, Bhandari D, Thapa K, Thapa P, Shrestha D, Chaudhary HK, Shrestha A, Parajuli H, Gupta BP.
    J Nepal Health Res Counc; 2016 May; 14(33):111-115. PubMed ID: 27885293
    [Abstract] [Full Text] [Related]

  • 62. Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
    Akpaka PE, Legall B, Padman J.
    West Indian Med J; 2010 Dec; 59(6):591-6. PubMed ID: 21702229
    [Abstract] [Full Text] [Related]

  • 63. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F.
    Acta Microbiol Immunol Hung; 2009 Mar; 56(1):89-99. PubMed ID: 19388560
    [Abstract] [Full Text] [Related]

  • 64. Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    Gandra S, Choi J, McElvania E, Green SJ, Harazin M, Thomson RB, Dantas G, Singh KS, Das S.
    Int J Antimicrob Agents; 2020 Mar; 55(3):105902. PubMed ID: 31954833
    [Abstract] [Full Text] [Related]

  • 65. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    Gülmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, Kocagoz S, Uzun O, Hascelik G, Livermore DM.
    Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
    [Abstract] [Full Text] [Related]

  • 66. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
    Khanfar HS, Bindayna KM, Senok AC, Botta GA.
    J Infect Dev Ctries; 2009 May 01; 3(4):295-9. PubMed ID: 19759493
    [Abstract] [Full Text] [Related]

  • 67. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.
    Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch T, Bardenstein R, Schwartz-Harari O, Carmeli Y, Israel ESBL Group.
    Diagn Microbiol Infect Dis; 2007 Feb 01; 57(2):201-5. PubMed ID: 17258084
    [Abstract] [Full Text] [Related]

  • 68. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H, Yang Q, Liao K, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Hu Z, Chu Y, Chen S, Cao B, Su J, Gui B, Duan Q, Zhang S, Shao H, Kong H, Badal RE, Xu Y.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):245-51. PubMed ID: 26482308
    [Abstract] [Full Text] [Related]

  • 69. [Comparison of phenotypic methods and polymerase chain reaction for the detection of carbapenemase production in clinical Klebsiella pneumoniae isolates].
    Tekintaş Y, Çilli F, Eraç B, Yaşar M, Aydemir SŞ, Hoşgör Limoncu M.
    Mikrobiyol Bul; 2017 Jul 01; 51(3):269-276. PubMed ID: 28929963
    [Abstract] [Full Text] [Related]

  • 70. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance.
    J Antimicrob Chemother; 2013 May 01; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [Abstract] [Full Text] [Related]

  • 71. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 01; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 72. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD, Bochum ET, van Mook-Vermulst SV, Handgraaf C, Klaassen T, Melchers WJ.
    Microb Drug Resist; 2010 Mar 01; 16(1):55-60. PubMed ID: 20001741
    [Abstract] [Full Text] [Related]

  • 73. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ, Ullberg M, Bernander S, Ericson E, Larsson P, Rydberg J, Törnqvist E, Melhus A.
    Scand J Infect Dis; 2006 Mar 01; 38(10):853-9. PubMed ID: 17008228
    [Abstract] [Full Text] [Related]

  • 74. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    Pornsinchai P, Chongtrakool P, Diraphat P, Siripanichgon K, Malathum K.
    Southeast Asian J Trop Med Public Health; 2015 Jan 01; 46(1):51-62. PubMed ID: 26513905
    [Abstract] [Full Text] [Related]

  • 75. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.
    Burgess DS, Hall RG, Lewis JS, Jorgensen JH, Patterson JE.
    Pharmacotherapy; 2003 Oct 01; 23(10):1232-7. PubMed ID: 14594340
    [Abstract] [Full Text] [Related]

  • 76. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
    Denisuik AJ, Karlowsky JA, Adam HJ, Baxter MR, Lagacé-Wiens PRS, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD.
    J Antimicrob Chemother; 2019 Aug 01; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
    [Abstract] [Full Text] [Related]

  • 77. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany.
    Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y.
    J Med Microbiol; 2009 Jul 01; 58(Pt 7):912-922. PubMed ID: 19502377
    [Abstract] [Full Text] [Related]

  • 78. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW.
    Korean J Lab Med; 2007 Oct 01; 27(5):344-50. PubMed ID: 18094599
    [Abstract] [Full Text] [Related]

  • 79. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ, Botha RF, Poswa X, Senekal M, Badal RE, Grolman DC, Richards GA, Feldman C, Boffard KD, Veller M, Joubert I, Pretorius J.
    Surg Infect (Larchmt); 2012 Feb 01; 13(1):43-9. PubMed ID: 22220506
    [Abstract] [Full Text] [Related]

  • 80. Phenotypic and genotypic detection of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Accra, Ghana.
    Dwomoh FP, Kotey FCN, Dayie NTKD, Osei MM, Amoa-Owusu F, Bannah V, Alzahrani FM, Halawani IF, Alzahrani KJ, Egyir B, Donkor ES.
    PLoS One; 2022 Feb 01; 17(12):e0279715. PubMed ID: 36584159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.